Printer Friendly
The Free Library
14,587,546 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Tamoxifen Therapy Should Last 5 Years.


The much-criticized drug tamoxifen tamoxifen (təmŏk`sĭfĕn'), synthetic hormone used in the treatment of breast cancer. Introduced in 1978, tamoxifen is used to prevent recurrences of cancer in women who have already undergone surgery to remove their tumors.  -- a synthetic hormone hormone, secretory substance carried from one gland or organ of the body via the bloodstream to more or less specific tissues, where it exerts some influence upon the metabolism of the target tissue.  widely prescribed pre·scribe  
v. pre·scribed, pre·scrib·ing, pre·scribes

v.tr.
1. To set down as a rule or guide; enjoin. See Synonyms at dictate.

2. To order the use of (a medicine or other treatment).
 to prevent recurrences of breast cancer -- should be taken for 5 years after early-stage cancers are removed and should then be stopped, two new studies show.

Tamoxifen has been engulfed in controversy ever since several major studies detected a steep increase in the incidence of uterine cancer uterine cancer

Malignant tumour of the uterus. Cancers affecting the lining of the uterus (endometrium) are the most common cancers of the female reproductive tract.
 among women taking the drug.

Now, a Swedish study of 3887 women indicates that those who took tamoxifen for 5 years had fewer recurrences of breast cancer than women who took the drug for just 2 years. And a U.S. study of 2818 women found that the benefits of 5 years' worth of tamoxifen therapy persisted for 5 years but that there was no additional advantage of a longer course of treatment or any likelihood that a longer course would be worth the accompanying risk of uterine cancer.

-- Science News, 11/23/97
COPYRIGHT 1997 Association of Labor Assistants & Childbirth Educators
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1997, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:breast cancer therapy
Publication:Special Delivery
Geographic Code:1USA
Date:Mar 22, 1997
Words:150
Previous Article:Estrogen and Breast Cancer.(risk factors)
Next Article:Abortion and Breast Cancer.(risk factors)
Topics:



Related Articles
Beating breast cancer: researchers are looking beyond conventional surgeries and chemotherapy.
Blocking breast cancer: do faulty estrogen receptors make a meaner, tougher tumor?
Tamoxifen quandary; promising cancer drug may hide a troubling dark side. (includes related articles)
Tamoxifen trial begins amid new concerns. (Brief Article)
Studies spark new tamoxifen controversy. (drug linked to endometrial cancer)
Tamoxifen therapy should last 5 years. (risks of uterine cancer may outweigh benefit of Tamoxifen after 5 years)(Biomedicine)(Brief Article)
Tamoxifen may not prevent breast cancer.(Brief Article)
Tamoxifen clears hurdle to preventive use.(breast cancer drug)
Protective progeny: peptide treats and prevents breast cancer.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles